Millions of brain-related injuries contribute to an unknown number of future diseases, yet we have no way to measure for definitive trauma or qualify the trauma experienced.
Head Genetics is a biotech company that was created to develop AI-assisted CDC protocol telehealth assessment with a saliva-based concussion assessment device.
HeadGen App is to take control of your concussion recovery. Easily track and manage concussion symptoms through personalized treatment plans from our doctors and progress monitoring.
Telehealth Integration
Quick access to a healthcare professional can minimize the risk of long-term effects by providing personalized guidance and monitoring from the very beginning. Immediate treatment not only aids in faster recovery but also reduces the chances of prolonged symptoms, allowing individuals to return to their daily activities safely and confidently.
Integrated Calendar
Syncs with users’ calendars to manage appointments, therapy sessions, and important milestones related to their recovery.
Survey and Assessment Tools
Administers regular surveys and assessments to track cognitive function, symptom changes, and overall well-being.
Treatment Tracker
Helps users monitor their treatment adherence and symptom progression throughout their recovery journey.
Educational Resources
Provides comprehensive information on concussions, including prevention tips, FAQs, and insights into recovery strategy.
Emergency Contacts and Resources
Offers quick access to emergency contacts, nearby medical facilities, and concussion specialists in case of urgent situations.
Head trauma happens everyday to millions
WORLDWIDE STATISTICS
The TBI injury diagnostic global market is approaching $1.75 billion & is expected to reach $3 billion by 2028.
70
million cases of concussion annually
40
of concussive events remain undiagnosed
The current protocol for assessing brain trauma is indeterminate and slow. That ends now.
The problem
Brain-related injuries contribute to an unknown number of future diseases, yet we have no way to measure for definitive trauma or qualify the trauma experienced
Concussion
Head Genetics saliva-based over the counter (OTC) assay device will be a game changer for the at home user and clinicians knowing that the leading cause of mTBI is caused by falling.
“the public is holding professional leagues accountable”
Recent viral media of player injuries have fans and viewers calling for complete protocol overhauls
Executive Team
FABIAN MACLAREN
CEO + CO-FOUNDER
Fabian Maclaren is a biotech, pharmaceutical and personal care executive with 17 years experience in the development, branding, marketing and scale up of successful brands through the largest retailers in the United States and abroad. Multiple successful exits, 4 yr old brand exited at $500m, Proven international market share, $700m international through 50+ partners, Vital retail relationships, $300m wholesale domestic, Engaged influencer networks and activations, 20+ online partners, Consumer database of > 250 million contacts
GEORGE GALLO
CMO + CO-FOUNDER
George brings 20 years of visionary branding, packaging, digital marketing and e-commerce. He meticulously brings products to life through immaculate and cutting-edge design that inspires. Driven by passion and innovation, George Gallo, Founder of his award-winning agency The George Gallo Company, has developed impeccable products for an arsenal of globally recognized brands including LVMH, Target, Fendi & Westfield and more. He is guided by a vision to push the boundaries of creativity and fuse technology and design. He is lead the designer of the Taj brand and bottle design.
YAN WANG, PH.D., MBA
CHIEF TECHNOLOGY OFFICER
Ph.D. in Organic Chemistry and MBA from University of Wisconsin, Madison, 25 years of C-level experience and key management positions in pharmaceutical. During his time as President at SPL (Scientific Protein Laboratories LLC), Yan led the company to triple net income. Played a pivotal role in multiple rounds of M&A and “change of control” transactions totaling over $1Billion
PAUL SLOWEY, PH.D.
CHIEF SCIENCE OFFICER
Ph.D. in Organic Chemistry from the University of Newcastle-Upon-Tyne, UK and a Postdoctoral Fellowship at the University of Victoria, BC, Canada. He has over 35 years of experience in the clinical diagnostic and pharmaceutical industries combined during of which he has held C-level positions. Dr. Slowey has 45 publications in peer-reviewed journals, including seven published book chapters, seventeen (17) issued patents, ten (10) filed patent applications. Has made a number of oral presentations at key scientific symposia on a variety of subjects including HIV diagnosis, liquid biopsy testing for cancer diagnosis, nucleic acid testing, the status of oral fluid testing, the Japanese Healthcare Business and Thyrotropin Receptor Antibody Assays for the Diagnosis of Graves’ Disease.
Dr. BALWANT RAI
INVENTOR
Over 35 patents globally and contributed to multiple scientific studies and journals over the past 15 years. His work as a reviewer for the National Research Foundation of South Africa and NASA’s Post-Doctoral Program has earned him critical acclaim among the science community and contributed to him being a leader in the saliva diagnostics and medical devices field
Received his BDS from PT Bhagwat Dayal Sharma (PTBDS) Post Graduate Institute of Medical Sciences, a leading government medical institution. While at PTBDS, Dr. Rai completed residency in Critical Care Medicine, Medical Diagnostics, Biotechnology and Lab-Based Medicine. Dr. Rai also received his MS from Catholic University, Belgium.